Company seeks new opportunities for use of mRNA therapeutics.
Up To Date
Latest News
U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first...
Funding to accelerate clinical progression of Iksuda's pipeline of new generation of antibody drug...
Lonza will expand its production capacity of Moderna’s mRNA vaccine mRNA1273 at its manufacturing site in...
The European Medicines Agency (EMA) has given the green light for vaccination of adolescents with Biontech's...
Senti Biosciences and Bayer subsidiary BlueRock Therapeutics form strategic partnership to combine iPSC and...
Share
